Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CODEXIS, INC.CDXS · Entity 6428 | Advisor | February 07, 2023 | February 09, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CODEXIS, INC.
Report date February 07, 2023 · Filed February 09, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 38,554 |
Reported balance
After 2023-02-07 transaction · row 1
1 source rowRow 1 · 2023-02-07 · Tax withholding · Disposed 1,224 · Balance 38,554 F1: Shares withheld by the Issuer on vesting of restricted stock units ("RSUs") solely to cover applicable withholding taxes. No shares were sold in the open market; the transaction reported herein was executed automatically upon the release of the RSUs upon the vesting thereof. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares withheld by the Issuer on vesting of restricted stock units ("RSUs") solely to cover applicable withholding taxes. No shares were sold in the open market; the transaction reported herein was executed automatically upon the release of the RSUs upon the vesting thereof.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
ABAXIS INC
Report date July 31, 2018 · Filed August 02, 2018
Section 16 reporting ended · disclosed 2018-08-02. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2018-07-31 transaction · row 1
1 source rowRow 1 · 2018-07-31 · Disposition to issuer · Disposed 15,500 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement") dated May 15, 2018, by and among Abaxis, Inc., a California corporation (the "Issuer"), Zoetis Inc., a Delaware corporation ("Parent"), and Zeus Merger Sub, Inc., a California corporation and an indirect wholly owned subsidiary of Parent ("Merger Sub"), on July 31, 2018, Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent. In connection with the Merger, these shares were cancelled and converted into the right to receive $83.00 in cash, without interest, per share, subject to the terms and conditions of the Merger Agreement (the "Merger Consideration"). |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2018-07-31 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2018-07-31 · Disposition to issuer · Disposed 7,000 · Balance 0 F2: Pursuant to the terms of the Merger Agreement, at the effective time of the Merger (the "Effective Time"), each of these unvested restricted stock units vested automatically in accordance with their existing terms and were cancelled and automatically converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. Each of these vested restricted stock units converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. F3: Not applicable. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2018-07-31 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2018-07-31 · Disposition to issuer · Disposed 6,300 · Balance 0 F2: Pursuant to the terms of the Merger Agreement, at the effective time of the Merger (the "Effective Time"), each of these unvested restricted stock units vested automatically in accordance with their existing terms and were cancelled and automatically converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. Each of these vested restricted stock units converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. F3: Not applicable. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2018-07-31 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2018-07-31 · Disposition to issuer · Disposed 7,650 · Balance 0 F2: Pursuant to the terms of the Merger Agreement, at the effective time of the Merger (the "Effective Time"), each of these unvested restricted stock units vested automatically in accordance with their existing terms and were cancelled and automatically converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. Each of these vested restricted stock units converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. F3: Not applicable. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2018-07-31 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2018-07-31 · Disposition to issuer · Disposed 8,550 · Balance 0 F2: Pursuant to the terms of the Merger Agreement, at the effective time of the Merger (the "Effective Time"), each of these unvested restricted stock units vested automatically in accordance with their existing terms and were cancelled and automatically converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. Each of these vested restricted stock units converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. F3: Not applicable. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2018-07-31 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2018-07-31 · Disposition to issuer · Disposed 9,000 · Balance 0 F2: Pursuant to the terms of the Merger Agreement, at the effective time of the Merger (the "Effective Time"), each of these unvested restricted stock units vested automatically in accordance with their existing terms and were cancelled and automatically converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. Each of these vested restricted stock units converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. F3: Not applicable. |
| Performance Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2018-07-31 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2018-07-31 · Disposition to issuer · Disposed 4,000 · Balance 0 F4: Pursuant to the terms of the Merger Agreement, at the Effective Time, each of these unvested performance restricted stock units vested automatically in accordance with their existing terms and were cancelled and automatically converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. Each of these vested performance restricted stock units converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. F3: Not applicable. |
| Performance Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2018-07-31 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2018-07-31 · Disposition to issuer · Disposed 4,000 · Balance 0 F4: Pursuant to the terms of the Merger Agreement, at the Effective Time, each of these unvested performance restricted stock units vested automatically in accordance with their existing terms and were cancelled and automatically converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. Each of these vested performance restricted stock units converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. F3: Not applicable. |
| Performance Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2018-07-31 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2018-07-31 · Disposition to issuer · Disposed 16,000 · Balance 0 F4: Pursuant to the terms of the Merger Agreement, at the Effective Time, each of these unvested performance restricted stock units vested automatically in accordance with their existing terms and were cancelled and automatically converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. Each of these vested performance restricted stock units converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. F3: Not applicable. |
| Performance Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2018-07-31 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2018-07-31 · Disposition to issuer · Disposed 16,000 · Balance 0 F4: Pursuant to the terms of the Merger Agreement, at the Effective Time, each of these unvested performance restricted stock units vested automatically in accordance with their existing terms and were cancelled and automatically converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. Each of these vested performance restricted stock units converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. F3: Not applicable. |
| Performance Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2018-07-31 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2018-07-31 · Disposition to issuer · Disposed 8,000 · Balance 0 F4: Pursuant to the terms of the Merger Agreement, at the Effective Time, each of these unvested performance restricted stock units vested automatically in accordance with their existing terms and were cancelled and automatically converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. Each of these vested performance restricted stock units converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. F3: Not applicable. |
| Performance Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2018-07-31 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2018-07-31 · Disposition to issuer · Disposed 8,000 · Balance 0 F4: Pursuant to the terms of the Merger Agreement, at the Effective Time, each of these unvested performance restricted stock units vested automatically in accordance with their existing terms and were cancelled and automatically converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. Each of these vested performance restricted stock units converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. F3: Not applicable. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement") dated May 15, 2018, by and among Abaxis, Inc., a California corporation (the "Issuer"), Zoetis Inc., a Delaware corporation ("Parent"), and Zeus Merger Sub, Inc., a California corporation and an indirect wholly owned subsidiary of Parent ("Merger Sub"), on July 31, 2018, Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent. In connection with the Merger, these shares were cancelled and converted into the right to receive $83.00 in cash, without interest, per share, subject to the terms and conditions of the Merger Agreement (the "Merger Consideration").
F2: Pursuant to the terms of the Merger Agreement, at the effective time of the Merger (the "Effective Time"), each of these unvested restricted stock units vested automatically in accordance with their existing terms and were cancelled and automatically converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. Each of these vested restricted stock units converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards.
F3: Not applicable.
F4: Pursuant to the terms of the Merger Agreement, at the Effective Time, each of these unvested performance restricted stock units vested automatically in accordance with their existing terms and were cancelled and automatically converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. Each of these vested performance restricted stock units converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 07, 2023 Filed Feb 9, 2023 16:21 UTC | CODEXIS, INC. CDXS · Entity 6428 | Tax withholdingCommon Stock | 1,224 | $6.51 | $7,968.24 |
DisclosureSEC source: 0001567619-23-002157 · doc1.xml · nonDerivative · entry 1 TAYLOR DEAN ROSS JR · CIK 0001646304 · Advisor 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,554 F1 · kind: Shares withheld by the Issuer on vesting of restricted stock units ("RSUs") solely to cover applicable withholding taxes. No shares were sold in the open market; the transaction reported herein was executed automatically upon the release of the RSUs upon the vesting thereof. Read SEC document |
| March 05, 2022 Filed Mar 8, 2022 16:08 UTC | CODEXIS, INC. CDXS · Entity 6428 | Tax withholdingCommon Stock | 2,414 | $19.30 | $46,590.20 |
DisclosureSEC source: 0001567619-22-006522 · doc1.xml · nonDerivative · entry 2 TAYLOR DEAN ROSS JR · CIK 0001646304 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,778 F1 · kind: Shares withheld by the Issuer on vesting of performance stock units solely to cover applicable withholding taxes. No shares were sold in the open market; the transaction reported herein was executed automatically upon the vesting of the Reporting Person's performance stock units. Read SEC document |
| March 05, 2022 Filed Mar 8, 2022 16:08 UTC | CODEXIS, INC. CDXS · Entity 6428 | Tax withholdingCommon Stock | 2,013 | $19.30 | $38,850.90 |
DisclosureSEC source: 0001567619-22-006522 · doc1.xml · nonDerivative · entry 1 TAYLOR DEAN ROSS JR · CIK 0001646304 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,192 F1 · kind: Shares withheld by the Issuer on vesting of performance stock units solely to cover applicable withholding taxes. No shares were sold in the open market; the transaction reported herein was executed automatically upon the vesting of the Reporting Person's performance stock units. Read SEC document |
| February 08, 2022 Filed Feb 9, 2022 21:42 UTC | CODEXIS, INC. CDXS · Entity 6428 | GrantStock Option (Right to Buy) · Derivative | 16,006 | $0.00 Strike: $26.16 | $0.00 |
DisclosureSEC source: 0001567619-22-003128 · doc1.xml · derivative · entry 3 TAYLOR DEAN ROSS JR · CIK 0001646304 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,006 Underlying: Common Stock · 16,006 shares Expires 2031-02-16 F3 · shares: On February 16, 2021, the issuer granted the reporting person an option that commences vesting in respect of a number of shares of the issuer's common stock determined based on the satisfaction of certain performance criteria for the fiscal year ended December 31, 2021 with any remaining shares forfeited. On February 8, 2022, the compensation committee of the issuer's board of directors certified achievement of the performance criteria at 72.75% of the target level, which will result in the vesting of the option with respect to 8,003 shares on March 5, 2022 and 8,003 shares on March 5, 2023, in each case subject to the reporting person's continued service to the issuer through such vesting date. F3 · derivative.exercise_date: On February 16, 2021, the issuer granted the reporting person an option that commences vesting in respect of a number of shares of the issuer's common stock determined based on the satisfaction of certain performance criteria for the fiscal year ended December 31, 2021 with any remaining shares forfeited. On February 8, 2022, the compensation committee of the issuer's board of directors certified achievement of the performance criteria at 72.75% of the target level, which will result in the vesting of the option with respect to 8,003 shares on March 5, 2022 and 8,003 shares on March 5, 2023, in each case subject to the reporting person's continued service to the issuer through such vesting date. Read SEC document |
| February 08, 2022 Filed Feb 9, 2022 21:42 UTC | CODEXIS, INC. CDXS · Entity 6428 | GrantCommon Stock | 11,640 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-003128 · doc1.xml · nonDerivative · entry 2 TAYLOR DEAN ROSS JR · CIK 0001646304 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,205 F2 · kind: Represent shares of common stock issuable pursuant to performance stock units for which achievement has been certified by the Issuer's compensation committee. Shares will be issued in two equal installments on each of March 5, 2022 and March 5, 2023, subject to continued employment through such date. Read SEC document |
| February 07, 2022 Filed Feb 9, 2022 21:42 UTC | CODEXIS, INC. CDXS · Entity 6428 | GrantStock Option (Right to Buy) · Derivative | 13,000 | $0.00 Strike: $19.39 | $0.00 |
DisclosureSEC source: 0001567619-22-003128 · doc1.xml · derivative · entry 4 TAYLOR DEAN ROSS JR · CIK 0001646304 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,000 Underlying: Common Stock · 13,000 shares Expires 2032-02-07 F4 · derivative.exercise_date: Option vests with respect to 25% of the shares subject thereto on February 7, 2023, with 1/48th of the shares vesting monthly thereafter, such that the option will be fully vested and exercisable on February 7, 2026. Read SEC document |
| February 07, 2022 Filed Feb 9, 2022 21:42 UTC | CODEXIS, INC. CDXS · Entity 6428 | GrantCommon Stock | 9,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-003128 · doc1.xml · nonDerivative · entry 1 TAYLOR DEAN ROSS JR · CIK 0001646304 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,205 F1 · shares: Restricted Stock Units ("RSUs") vest 1/3 annually from February 7, 2022 such that the RSUs will be fully vested on February 7, 2025. Each RSU represents a contingent right to receive one share of Codexis common stock. Read SEC document |
| March 05, 2021 Filed Mar 9, 2021 16:19 UTC | CODEXIS, INC. CDXS · Entity 6428 | Tax withholdingCommon Stock | 2,419 | $19.51 | $47,194.69 |
DisclosureSEC source: 0001567619-21-005915 · doc1.xml · nonDerivative · entry 1 TAYLOR DEAN ROSS JR · CIK 0001646304 · SVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,565 F1 · kind: Shares withheld by the Issuer on vesting of performance stock units solely to cover applicable withholding taxes. No shares were sold in the open market; the transaction reported herein was executed automatically upon the vesting of the Reporting Person's performance stock units. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 16:11 UTC | CODEXIS, INC. CDXS · Entity 6428 | GrantStock Option (Right to Buy) · Derivative | 17,600 | $0.00 Strike: $14.43 | $0.00 |
DisclosureSEC source: 0001567619-21-004396 · doc1.xml · derivative · entry 5 TAYLOR DEAN ROSS JR · CIK 0001646304 · SVP, Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,600 Underlying: Common Stock · 17,600 shares Expires 2030-02-11 F5 · derivative.exercise_date: On February 11, 2020, the issuer granted the reporting person an option that commences vesting in respect of a number of shares of the issuer's common stock determined based on the satisfaction of certain performance criteria for the fiscal year ended December 31, 2020 with any remaining shares forfeited. On February 16, 2021, the compensation committee of the issuer's board of directors certified achievement of the performance criteria at 88% of the target level, which will result in the vesting of the option with respect to 8,800 shares on March 5, 2021 and 8,800 shares on March 5, 2022, in each case subject to the reporting person's continued service to the issuer through such vesting date. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 16:11 UTC | CODEXIS, INC. CDXS · Entity 6428 | GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $26.16 | $0.00 |
DisclosureSEC source: 0001567619-21-004396 · doc1.xml · derivative · entry 4 TAYLOR DEAN ROSS JR · CIK 0001646304 · SVP, Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2031-02-16 F4 · derivative.exercise_date: Option vests with respect to 25% of the shares subject thereto on February 16, 2022, with 1/48th of the shares vesting monthly thereafter, such that the option will be fully vested and exercisable on February 16, 2025. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 16:11 UTC | CODEXIS, INC. CDXS · Entity 6428 | GrantCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-004396 · doc1.xml · nonDerivative · entry 3 TAYLOR DEAN ROSS JR · CIK 0001646304 · SVP, Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,984 F3 · shares: RSUs vest 1/3 annually from February 16, 2021 such that the RSUs will be fully vested on February 16, 2024. Each RSU represents a contingent right to receive one share of Codexis common stock. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 16:11 UTC | CODEXIS, INC. CDXS · Entity 6428 | GrantCommon Stock | 14,080 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-004396 · doc1.xml · nonDerivative · entry 2 TAYLOR DEAN ROSS JR · CIK 0001646304 · SVP, Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,984 F2 · kind: Represent shares of common stock issuable pursuant to performance stock units for which achievement has been certified by the Issuer's compensation committee. Shares will be issued in two equal installments on each of March 5, 2021 and March 5, 2022, subject to continued employment through such date. Read SEC document |
| February 11, 2021 Filed Feb 18, 2021 16:11 UTC | CODEXIS, INC. CDXS · Entity 6428 | Tax withholdingCommon Stock | 1,096 | $26.67 | $29,230.32 |
DisclosureSEC source: 0001567619-21-004396 · doc1.xml · nonDerivative · entry 1 TAYLOR DEAN ROSS JR · CIK 0001646304 · SVP, Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,904 F1 · kind: Shares withheld by the Issuer on vesting of restricted stock units ("RSUs") solely to cover applicable withholding taxes. No shares were sold in the open market; the transaction reported herein was executed automatically upon the release of the RSUs upon the vesting thereof. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 16:37 UTC | CODEXIS, INC. CDXS · Entity 6428 | GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $14.43 | $0.00 |
DisclosureSEC source: 0001567619-20-003345 · doc1.xml · derivative · entry 2 TAYLOR DEAN ROSS JR · CIK 0001646304 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2030-02-11 F3 · derivative.exercise_date: Option vests with respect to 25% of the shares subject thereto on February 11, 2021, with 1/48th of the shares vesting monthly thereafter, such that the option will be fully vested and exercisable on February 11, 2024. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 16:37 UTC | CODEXIS, INC. CDXS · Entity 6428 | GrantCommon Stock | 8,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-20-003345 · doc1.xml · nonDerivative · entry 1 TAYLOR DEAN ROSS JR · CIK 0001646304 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 F1 · shares: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Codexis common stock. F2 · shares: RSUs vest 1/3 annually from February 11, 2020 such that the RSUs will be fully vested on February 11, 2023. Read SEC document |
| August 20, 2019 Filed Aug 22, 2019 16:20 UTC | CODEXIS, INC. CDXS · Entity 6428 | GrantStock Option (Right to Buy) · Derivative | 42,285 | $0.00 Strike: $13.01 | $0.00 |
DisclosureSEC source: 0001567619-19-017470 · doc1.xml · derivative · entry 1 TAYLOR DEAN ROSS JR · CIK 0001646304 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,285 Underlying: Common Stock · 42,285 shares Expires 2029-08-20 F1 · derivative.exercise_date: Option vests with respect to 25% of the shares subject thereto on August 19, 2020, with 1/48th of the shares vesting monthly thereafter, such that the option will be fully vested and exercisable on August 19, 2023. Read SEC document |
| July 31, 2018 Filed Aug 2, 2018 19:46 UTC | ABAXIS INC ABAX · Entity 164580 | Disposition to issuerPerformance Restricted Stock Units · Derivative | 8,000 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001140361-18-035265 · doc1.xml · derivative · entry 12 TAYLOR DEAN ROSS JR · CIK 0001646304 · CFO and VP of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,000 shares Expires not disclosed F4 · price: Pursuant to the terms of the Merger Agreement, at the Effective Time, each of these unvested performance restricted stock units vested automatically in accordance with their existing terms and were cancelled and automatically converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. Each of these vested performance restricted stock units converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. F4 · derivative.exercise_date: Pursuant to the terms of the Merger Agreement, at the Effective Time, each of these unvested performance restricted stock units vested automatically in accordance with their existing terms and were cancelled and automatically converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. Each of these vested performance restricted stock units converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. F3 · derivative.expiration_date: Not applicable. F4 · balance_after: Pursuant to the terms of the Merger Agreement, at the Effective Time, each of these unvested performance restricted stock units vested automatically in accordance with their existing terms and were cancelled and automatically converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. Each of these vested performance restricted stock units converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. Read SEC document |
| July 31, 2018 Filed Aug 2, 2018 19:46 UTC | ABAXIS INC ABAX · Entity 164580 | Disposition to issuerPerformance Restricted Stock Units · Derivative | 8,000 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001140361-18-035265 · doc1.xml · derivative · entry 11 TAYLOR DEAN ROSS JR · CIK 0001646304 · CFO and VP of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,000 shares Expires not disclosed F4 · price: Pursuant to the terms of the Merger Agreement, at the Effective Time, each of these unvested performance restricted stock units vested automatically in accordance with their existing terms and were cancelled and automatically converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. Each of these vested performance restricted stock units converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. F4 · derivative.exercise_date: Pursuant to the terms of the Merger Agreement, at the Effective Time, each of these unvested performance restricted stock units vested automatically in accordance with their existing terms and were cancelled and automatically converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. Each of these vested performance restricted stock units converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. F3 · derivative.expiration_date: Not applicable. F4 · balance_after: Pursuant to the terms of the Merger Agreement, at the Effective Time, each of these unvested performance restricted stock units vested automatically in accordance with their existing terms and were cancelled and automatically converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. Each of these vested performance restricted stock units converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. Read SEC document |
| July 31, 2018 Filed Aug 2, 2018 19:46 UTC | ABAXIS INC ABAX · Entity 164580 | Disposition to issuerPerformance Restricted Stock Units · Derivative | 16,000 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001140361-18-035265 · doc1.xml · derivative · entry 10 TAYLOR DEAN ROSS JR · CIK 0001646304 · CFO and VP of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,000 shares Expires not disclosed F4 · price: Pursuant to the terms of the Merger Agreement, at the Effective Time, each of these unvested performance restricted stock units vested automatically in accordance with their existing terms and were cancelled and automatically converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. Each of these vested performance restricted stock units converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. F4 · derivative.exercise_date: Pursuant to the terms of the Merger Agreement, at the Effective Time, each of these unvested performance restricted stock units vested automatically in accordance with their existing terms and were cancelled and automatically converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. Each of these vested performance restricted stock units converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. F3 · derivative.expiration_date: Not applicable. F4 · balance_after: Pursuant to the terms of the Merger Agreement, at the Effective Time, each of these unvested performance restricted stock units vested automatically in accordance with their existing terms and were cancelled and automatically converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. Each of these vested performance restricted stock units converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. Read SEC document |
| July 31, 2018 Filed Aug 2, 2018 19:46 UTC | ABAXIS INC ABAX · Entity 164580 | Disposition to issuerPerformance Restricted Stock Units · Derivative | 16,000 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001140361-18-035265 · doc1.xml · derivative · entry 9 TAYLOR DEAN ROSS JR · CIK 0001646304 · CFO and VP of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,000 shares Expires not disclosed F4 · price: Pursuant to the terms of the Merger Agreement, at the Effective Time, each of these unvested performance restricted stock units vested automatically in accordance with their existing terms and were cancelled and automatically converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. Each of these vested performance restricted stock units converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. F4 · derivative.exercise_date: Pursuant to the terms of the Merger Agreement, at the Effective Time, each of these unvested performance restricted stock units vested automatically in accordance with their existing terms and were cancelled and automatically converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. Each of these vested performance restricted stock units converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. F3 · derivative.expiration_date: Not applicable. F4 · balance_after: Pursuant to the terms of the Merger Agreement, at the Effective Time, each of these unvested performance restricted stock units vested automatically in accordance with their existing terms and were cancelled and automatically converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. Each of these vested performance restricted stock units converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. Read SEC document |
| July 31, 2018 Filed Aug 2, 2018 19:46 UTC | ABAXIS INC ABAX · Entity 164580 | Disposition to issuerPerformance Restricted Stock Units · Derivative | 4,000 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001140361-18-035265 · doc1.xml · derivative · entry 8 TAYLOR DEAN ROSS JR · CIK 0001646304 · CFO and VP of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,000 shares Expires not disclosed F4 · price: Pursuant to the terms of the Merger Agreement, at the Effective Time, each of these unvested performance restricted stock units vested automatically in accordance with their existing terms and were cancelled and automatically converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. Each of these vested performance restricted stock units converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. F4 · derivative.exercise_date: Pursuant to the terms of the Merger Agreement, at the Effective Time, each of these unvested performance restricted stock units vested automatically in accordance with their existing terms and were cancelled and automatically converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. Each of these vested performance restricted stock units converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. F3 · derivative.expiration_date: Not applicable. F4 · balance_after: Pursuant to the terms of the Merger Agreement, at the Effective Time, each of these unvested performance restricted stock units vested automatically in accordance with their existing terms and were cancelled and automatically converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. Each of these vested performance restricted stock units converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. Read SEC document |
| July 31, 2018 Filed Aug 2, 2018 19:46 UTC | ABAXIS INC ABAX · Entity 164580 | Disposition to issuerPerformance Restricted Stock Units · Derivative | 4,000 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001140361-18-035265 · doc1.xml · derivative · entry 7 TAYLOR DEAN ROSS JR · CIK 0001646304 · CFO and VP of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,000 shares Expires not disclosed F4 · price: Pursuant to the terms of the Merger Agreement, at the Effective Time, each of these unvested performance restricted stock units vested automatically in accordance with their existing terms and were cancelled and automatically converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. Each of these vested performance restricted stock units converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. F4 · derivative.exercise_date: Pursuant to the terms of the Merger Agreement, at the Effective Time, each of these unvested performance restricted stock units vested automatically in accordance with their existing terms and were cancelled and automatically converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. Each of these vested performance restricted stock units converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. F3 · derivative.expiration_date: Not applicable. F4 · balance_after: Pursuant to the terms of the Merger Agreement, at the Effective Time, each of these unvested performance restricted stock units vested automatically in accordance with their existing terms and were cancelled and automatically converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. Each of these vested performance restricted stock units converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. Read SEC document |
| July 31, 2018 Filed Aug 2, 2018 19:46 UTC | ABAXIS INC ABAX · Entity 164580 | Disposition to issuerRestricted Stock Units · Derivative | 9,000 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001140361-18-035265 · doc1.xml · derivative · entry 6 TAYLOR DEAN ROSS JR · CIK 0001646304 · CFO and VP of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,000 shares Expires not disclosed F2 · price: Pursuant to the terms of the Merger Agreement, at the effective time of the Merger (the "Effective Time"), each of these unvested restricted stock units vested automatically in accordance with their existing terms and were cancelled and automatically converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. Each of these vested restricted stock units converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. F2 · derivative.exercise_date: Pursuant to the terms of the Merger Agreement, at the effective time of the Merger (the "Effective Time"), each of these unvested restricted stock units vested automatically in accordance with their existing terms and were cancelled and automatically converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. Each of these vested restricted stock units converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. F3 · derivative.expiration_date: Not applicable. F2 · balance_after: Pursuant to the terms of the Merger Agreement, at the effective time of the Merger (the "Effective Time"), each of these unvested restricted stock units vested automatically in accordance with their existing terms and were cancelled and automatically converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. Each of these vested restricted stock units converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. Read SEC document |
| July 31, 2018 Filed Aug 2, 2018 19:46 UTC | ABAXIS INC ABAX · Entity 164580 | Disposition to issuerRestricted Stock Units · Derivative | 8,550 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001140361-18-035265 · doc1.xml · derivative · entry 5 TAYLOR DEAN ROSS JR · CIK 0001646304 · CFO and VP of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,550 shares Expires not disclosed F2 · price: Pursuant to the terms of the Merger Agreement, at the effective time of the Merger (the "Effective Time"), each of these unvested restricted stock units vested automatically in accordance with their existing terms and were cancelled and automatically converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. Each of these vested restricted stock units converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. F2 · derivative.exercise_date: Pursuant to the terms of the Merger Agreement, at the effective time of the Merger (the "Effective Time"), each of these unvested restricted stock units vested automatically in accordance with their existing terms and were cancelled and automatically converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. Each of these vested restricted stock units converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. F3 · derivative.expiration_date: Not applicable. F2 · balance_after: Pursuant to the terms of the Merger Agreement, at the effective time of the Merger (the "Effective Time"), each of these unvested restricted stock units vested automatically in accordance with their existing terms and were cancelled and automatically converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. Each of these vested restricted stock units converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. Read SEC document |
| July 31, 2018 Filed Aug 2, 2018 19:46 UTC | ABAXIS INC ABAX · Entity 164580 | Disposition to issuerRestricted Stock Units · Derivative | 7,650 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001140361-18-035265 · doc1.xml · derivative · entry 4 TAYLOR DEAN ROSS JR · CIK 0001646304 · CFO and VP of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,650 shares Expires not disclosed F2 · price: Pursuant to the terms of the Merger Agreement, at the effective time of the Merger (the "Effective Time"), each of these unvested restricted stock units vested automatically in accordance with their existing terms and were cancelled and automatically converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. Each of these vested restricted stock units converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. F2 · derivative.exercise_date: Pursuant to the terms of the Merger Agreement, at the effective time of the Merger (the "Effective Time"), each of these unvested restricted stock units vested automatically in accordance with their existing terms and were cancelled and automatically converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. Each of these vested restricted stock units converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. F3 · derivative.expiration_date: Not applicable. F2 · balance_after: Pursuant to the terms of the Merger Agreement, at the effective time of the Merger (the "Effective Time"), each of these unvested restricted stock units vested automatically in accordance with their existing terms and were cancelled and automatically converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. Each of these vested restricted stock units converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. Read SEC document |
| July 31, 2018 Filed Aug 2, 2018 19:46 UTC | ABAXIS INC ABAX · Entity 164580 | Disposition to issuerRestricted Stock Units · Derivative | 6,300 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001140361-18-035265 · doc1.xml · derivative · entry 3 TAYLOR DEAN ROSS JR · CIK 0001646304 · CFO and VP of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,300 shares Expires not disclosed F2 · price: Pursuant to the terms of the Merger Agreement, at the effective time of the Merger (the "Effective Time"), each of these unvested restricted stock units vested automatically in accordance with their existing terms and were cancelled and automatically converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. Each of these vested restricted stock units converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. F2 · derivative.exercise_date: Pursuant to the terms of the Merger Agreement, at the effective time of the Merger (the "Effective Time"), each of these unvested restricted stock units vested automatically in accordance with their existing terms and were cancelled and automatically converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. Each of these vested restricted stock units converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. F3 · derivative.expiration_date: Not applicable. F2 · balance_after: Pursuant to the terms of the Merger Agreement, at the effective time of the Merger (the "Effective Time"), each of these unvested restricted stock units vested automatically in accordance with their existing terms and were cancelled and automatically converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. Each of these vested restricted stock units converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. Read SEC document |
| July 31, 2018 Filed Aug 2, 2018 19:46 UTC | ABAXIS INC ABAX · Entity 164580 | Disposition to issuerRestricted Stock Units · Derivative | 7,000 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001140361-18-035265 · doc1.xml · derivative · entry 2 TAYLOR DEAN ROSS JR · CIK 0001646304 · CFO and VP of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,000 shares Expires not disclosed F2 · price: Pursuant to the terms of the Merger Agreement, at the effective time of the Merger (the "Effective Time"), each of these unvested restricted stock units vested automatically in accordance with their existing terms and were cancelled and automatically converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. Each of these vested restricted stock units converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. F2 · derivative.exercise_date: Pursuant to the terms of the Merger Agreement, at the effective time of the Merger (the "Effective Time"), each of these unvested restricted stock units vested automatically in accordance with their existing terms and were cancelled and automatically converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. Each of these vested restricted stock units converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. F3 · derivative.expiration_date: Not applicable. F2 · balance_after: Pursuant to the terms of the Merger Agreement, at the effective time of the Merger (the "Effective Time"), each of these unvested restricted stock units vested automatically in accordance with their existing terms and were cancelled and automatically converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. Each of these vested restricted stock units converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards. Read SEC document |
| July 31, 2018 Filed Aug 2, 2018 19:46 UTC | ABAXIS INC ABAX · Entity 164580 | Disposition to issuerCommon Stock | 15,500 | $83.00 | $1,286,500.00 |
DisclosureSEC source: 0001140361-18-035265 · doc1.xml · nonDerivative · entry 1 TAYLOR DEAN ROSS JR · CIK 0001646304 · CFO and VP of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement") dated May 15, 2018, by and among Abaxis, Inc., a California corporation (the "Issuer"), Zoetis Inc., a Delaware corporation ("Parent"), and Zeus Merger Sub, Inc., a California corporation and an indirect wholly owned subsidiary of Parent ("Merger Sub"), on July 31, 2018, Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent. In connection with the Merger, these shares were cancelled and converted into the right to receive $83.00 in cash, without interest, per share, subject to the terms and conditions of the Merger Agreement (the "Merger Consideration"). Read SEC document |
| May 04, 2018 Filed May 8, 2018 18:31 UTC | ABAXIS INC ABAX · Entity 164580 | Exercise / conversionPerformance Restricted Stock Units · Derivative | 4,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-022299 · doc1.xml · derivative · entry 6 TAYLOR DEAN ROSS JR · CIK 0001646304 · CFO and VP of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock · 4,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each restricted stock unit represents a contingent right to receive one share of Abaxis common stock. F5 · derivative.exercise_date: Granted under the Abaxis 2014 Equity Incentive Plan. Performance restricted stock units vest based on achievement of income from operations in excess of 100% of target for fiscal 2016 and based on time vesting of 50% on May 4, 2018 and 50% on May 4, 2019. F3 · derivative.expiration_date: Not applicable. Read SEC document |
| May 04, 2018 Filed May 8, 2018 18:31 UTC | ABAXIS INC ABAX · Entity 164580 | Exercise / conversionPerformance Restricted Stock Units · Derivative | 4,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-022299 · doc1.xml · derivative · entry 5 TAYLOR DEAN ROSS JR · CIK 0001646304 · CFO and VP of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock · 4,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each restricted stock unit represents a contingent right to receive one share of Abaxis common stock. F4 · derivative.exercise_date: Granted under the Abaxis 2014 Equity Incentive Plan. Performance restricted stock units vest based on achievement of income from operations in excess of 90% of target for fiscal 2016 and based on time vesting of 50% on May 4, 2018 and 50% on May 4, 2019. F3 · derivative.expiration_date: Not applicable. Read SEC document |
| May 04, 2018 Filed May 8, 2018 18:31 UTC | ABAXIS INC ABAX · Entity 164580 | Exercise / conversionRestricted Stock Units · Derivative | 1,350 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-022299 · doc1.xml · derivative · entry 4 TAYLOR DEAN ROSS JR · CIK 0001646304 · CFO and VP of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,300 Underlying: Common Stock · 1,350 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each restricted stock unit represents a contingent right to receive one share of Abaxis common stock. F1 · shares: Each restricted stock unit represents a contingent right to receive one share of Abaxis common stock. F2 · derivative.exercise_date: Granted under the Abaxis 2014 Equity Incentive Plan. Restricted stock units vest as to 5% after the first year; then vest as to 10% after the second year; then vest as to 15% after the third year; and the remaining 70% after the fourth year. F3 · derivative.expiration_date: Not applicable. Read SEC document |
| May 04, 2018 Filed May 8, 2018 18:31 UTC | ABAXIS INC ABAX · Entity 164580 | Exercise / conversionCommon Stock | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-022299 · doc1.xml · nonDerivative · entry 3 TAYLOR DEAN ROSS JR · CIK 0001646304 · CFO and VP of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 04, 2018 Filed May 8, 2018 18:31 UTC | ABAXIS INC ABAX · Entity 164580 | Exercise / conversionCommon Stock | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-022299 · doc1.xml · nonDerivative · entry 2 TAYLOR DEAN ROSS JR · CIK 0001646304 · CFO and VP of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 04, 2018 Filed May 8, 2018 18:31 UTC | ABAXIS INC ABAX · Entity 164580 | Exercise / conversionCommon Stock | 1,350 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-022299 · doc1.xml · nonDerivative · entry 1 TAYLOR DEAN ROSS JR · CIK 0001646304 · CFO and VP of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 02, 2018 Filed May 3, 2018 19:32 UTC | ABAXIS INC ABAX · Entity 164580 | Exercise / conversionRestricted Stock Units · Derivative | 900 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-021605 · doc1.xml · derivative · entry 4 TAYLOR DEAN ROSS JR · CIK 0001646304 · CFO and VP of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,650 Underlying: Common Stock · 900 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each restricted stock unit represents a contingent right to receive one share of Abaxis common stock. F2 · derivative.exercise_date: Granted under the Abaxis 2014 Equity Incentive Plan. Restricted stock units vest as to 5% after the first year; then vest as to 10% after the second year; then vest as to 15% after the third year; and the remaining 70% after the fourth year. F3 · derivative.expiration_date: Not applicable. Read SEC document |
| May 02, 2018 Filed May 3, 2018 19:32 UTC | ABAXIS INC ABAX · Entity 164580 | Exercise / conversionCommon Stock | 900 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-021605 · doc1.xml · nonDerivative · entry 2 TAYLOR DEAN ROSS JR · CIK 0001646304 · CFO and VP of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,150 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 01, 2018 Filed May 3, 2018 19:32 UTC | ABAXIS INC ABAX · Entity 164580 | Exercise / conversionRestricted Stock Units · Derivative | 450 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-021605 · doc1.xml · derivative · entry 3 TAYLOR DEAN ROSS JR · CIK 0001646304 · CFO and VP of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,550 Underlying: Common Stock · 450 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each restricted stock unit represents a contingent right to receive one share of Abaxis common stock. F2 · derivative.exercise_date: Granted under the Abaxis 2014 Equity Incentive Plan. Restricted stock units vest as to 5% after the first year; then vest as to 10% after the second year; then vest as to 15% after the third year; and the remaining 70% after the fourth year. F3 · derivative.expiration_date: Not applicable. Read SEC document |
| May 01, 2018 Filed May 3, 2018 19:32 UTC | ABAXIS INC ABAX · Entity 164580 | Exercise / conversionCommon Stock | 450 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-021605 · doc1.xml · nonDerivative · entry 1 TAYLOR DEAN ROSS JR · CIK 0001646304 · CFO and VP of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 30, 2018 Filed May 2, 2018 19:44 UTC | ABAXIS INC ABAX · Entity 164580 | GrantPerformance Restricted Stock Units · Derivative | 16,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-021367 · doc1.xml · derivative · entry 2 TAYLOR DEAN ROSS JR · CIK 0001646304 · CFO and VP of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,000 Underlying: Common Stock · 16,000 shares Expires not disclosed F1 · security: Each restricted stock unit represents a contingent right to receive one share of Abaxis common stock. F4 · derivative.exercise_date: Granted under the Abaxis 2014 Equity Incentive Plan. Performance restricted stock units vest based on achievement of income from continuing operations before income tax provision in excess of 95% of target for fiscal 2019 and based on time vesting of 50% on April 30, 2021 and 50% on April 30, 2022. F3 · derivative.expiration_date: Not applicable. Read SEC document |
| April 30, 2018 Filed May 2, 2018 19:44 UTC | ABAXIS INC ABAX · Entity 164580 | GrantRestricted Stock Units · Derivative | 9,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-021367 · doc1.xml · derivative · entry 1 TAYLOR DEAN ROSS JR · CIK 0001646304 · CFO and VP of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,000 Underlying: Common Stock · 9,000 shares Expires not disclosed F1 · security: Each restricted stock unit represents a contingent right to receive one share of Abaxis common stock. F2 · derivative.exercise_date: Granted under the Abaxis 2014 Equity Incentive Plan. Restricted stock units vest as to 5% after the first year; then vest as to 10% after the second year; then vest as to 15% after the third year; and the remaining 70% after the fourth year. F3 · derivative.expiration_date: Not applicable. Read SEC document |
| October 26, 2017 Filed Oct 30, 2017 16:18 UTC | ABAXIS INC ABAX · Entity 164580 | Exercise / conversionRestricted Stock Units · Derivative | 1,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-040040 · doc1.xml · derivative · entry 2 TAYLOR DEAN ROSS JR · CIK 0001646304 · CFO and VP of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,000 Underlying: Common Stock · 1,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each restricted stock unit represents a contingent right to receive one share of Abaxis common stock. F2 · derivative.exercise_date: Granted under the Abaxis 2014 Equity Incentive Plan. Restricted stock units vest as to 5% after the first year; then vest as to 10% after the second year; then vest as to 15% after the third year; and the remaining 70% after the fourth year. F3 · derivative.expiration_date: Not applicable. Read SEC document |
| October 26, 2017 Filed Oct 30, 2017 16:18 UTC | ABAXIS INC ABAX · Entity 164580 | Exercise / conversionCommon Stock | 1,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-040040 · doc1.xml · nonDerivative · entry 1 TAYLOR DEAN ROSS JR · CIK 0001646304 · CFO and VP of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,800 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 04, 2017 Filed May 8, 2017 19:18 UTC | ABAXIS INC ABAX · Entity 164580 | Exercise / conversionRestricted Stock Units · Derivative | 900 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-018927 · doc1.xml · derivative · entry 2 TAYLOR DEAN ROSS JR · CIK 0001646304 · CFO and VP of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,650 Underlying: Common Stock · 900 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each restricted stock unit represents a contingent right to receive one share of Abaxis common stock. F2 · derivative.exercise_date: Granted under the Abaxis 2014 Equity Incentive Plan. Restricted stock units vest as to 5% after the first year; then vest as to 10% after the second year; then vest as to 15% after the third year; and the remaining 70% after the fourth year. F3 · derivative.expiration_date: Not applicable. Read SEC document |
| May 04, 2017 Filed May 8, 2017 19:18 UTC | ABAXIS INC ABAX · Entity 164580 | Exercise / conversionCommon Stock | 900 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-018927 · doc1.xml · nonDerivative · entry 1 TAYLOR DEAN ROSS JR · CIK 0001646304 · CFO and VP of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,300 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 02, 2017 Filed May 3, 2017 21:29 UTC | ABAXIS INC ABAX · Entity 164580 | Exercise / conversionRestricted Stock Units · Derivative | 450 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-018336 · doc1.xml · derivative · entry 4 TAYLOR DEAN ROSS JR · CIK 0001646304 · CFO and VP of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,550 Underlying: Common Stock · 450 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Granted under the Abaxis 2014 Equity Incentive Plan. Restricted stock units vest as to 5% after the first year; then vest as to 10% after the second year; then vest as to 15% after the third year; and the remaining 70% after the fourth year. F3 · derivative.expiration_date: Not applicable. Read SEC document |
| May 02, 2017 Filed May 3, 2017 21:29 UTC | ABAXIS INC ABAX · Entity 164580 | Exercise / conversionCommon Stock | 450 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-018336 · doc1.xml · nonDerivative · entry 1 TAYLOR DEAN ROSS JR · CIK 0001646304 · CFO and VP of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,400 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 02, 2017 Filed May 10, 2017 18:00 UTC Amendment | ABAXIS INC ABAX · Entity 164580 | Exercise / conversionRestricted Stock Units · Derivative | 450 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-019447 · doc1.xml · derivative · entry 4 TAYLOR DEAN ROSS JR · CIK 0001646304 · CFO and VP of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,550 Underlying: Common Stock · 450 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each restricted stock unit represents a contingent right to receive one share of Abaxis common stock. F5 · shares: This amendment is filed to correctly report the restricted stock units under the disposed column. F2 · derivative.exercise_date: Granted under the Abaxis 2014 Equity Incentive Plan. Restricted stock units vest as to 5% after the first year; then vest as to 10% after the second year; then vest as to 15% after the third year; and the remaining 70% after the fourth year. F3 · derivative.expiration_date: Not applicable. Read SEC document |
| May 02, 2017 Filed May 10, 2017 18:00 UTC Amendment | ABAXIS INC ABAX · Entity 164580 | Exercise / conversionCommon Stock | 450 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-019447 · doc1.xml · nonDerivative · entry 1 TAYLOR DEAN ROSS JR · CIK 0001646304 · CFO and VP of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,400 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 01, 2017 Filed May 3, 2017 21:29 UTC | ABAXIS INC ABAX · Entity 164580 | GrantPerformance Restricted Stock Units · Derivative | 16,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-018336 · doc1.xml · derivative · entry 3 TAYLOR DEAN ROSS JR · CIK 0001646304 · CFO and VP of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,000 Underlying: Common Stock · 16,000 shares Expires not disclosed F1 · security: Each restricted stock unit represents a contingent right to receive one share of Abaxis common stock. F4 · derivative.exercise_date: Granted under the Abaxis 2014 Equity Incentive Plan. Performance restricted stock units vest based on achievement of income from continuing operations before income tax provision in excess of 90% of target for fiscal 2018 and based on time vesting of 50% on May 1, 2020 and 50% on May 1, 2021. F3 · derivative.expiration_date: Not applicable. Read SEC document |
| May 01, 2017 Filed May 3, 2017 21:29 UTC | ABAXIS INC ABAX · Entity 164580 | GrantRestricted Stock Units · Derivative | 9,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-018336 · doc1.xml · derivative · entry 2 TAYLOR DEAN ROSS JR · CIK 0001646304 · CFO and VP of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,000 Underlying: Common Stock · 9,000 shares Expires not disclosed F1 · security: Each restricted stock unit represents a contingent right to receive one share of Abaxis common stock. F2 · derivative.exercise_date: Granted under the Abaxis 2014 Equity Incentive Plan. Restricted stock units vest as to 5% after the first year; then vest as to 10% after the second year; then vest as to 15% after the third year; and the remaining 70% after the fourth year. F3 · derivative.expiration_date: Not applicable. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.